中基健康(000972.SZ):紅色番茄擬公開掛牌轉讓部分閒置資產
格隆匯9月26日丨中基健康(000972.SZ)公佈,公司為更好地保護上市公司及全體股東利益,進一步改善公司資產結構,整合優化資源,降低公司負擔,推進業務轉型,改善公司資產質量,增強公司的持續發展能力和盈利能力,公司下屬全資子公司新疆中基紅色番茄產業有限公司(簡稱“紅色番茄”)擬對部分閒置資產進行處置。
本次交易為紅色番茄通過在新疆產權交易所公開掛牌的方式轉讓原和靜中基天河蕃茄製品有限責任公司(該公司於2019年9月9日註銷,所有資產吸收合併入紅色番茄)的土地使用權、房屋建築物及構築物、機器設備。紅色番茄擬處置資產的評估價值為802.67萬元,最終成交價格以摘牌價格為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.